No relationship is indicated between FHIT expression and clinicopathologic prognostic parameters in early stage cervical carcinoma

This publication has 12 references indexed in Scilit:

• Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within theFHIT gene: Evaluation of allelic imbalance atFHIT, RB1 andTP53 in relation to survival
  International Journal of Cancer, 2000
• A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix
  British Journal of Cancer, 1999
• AberrantFHIT transcripts in squamous cell carcinoma of the uterine cervix
  International Journal of Cancer, 1998
• Variable FHIT transcripts in non‐neoplastic tissues
  Genes, Chromosomes and Cancer, 1997
• FHIT gene alterations in head and neck squamous cell carcinomas.
  Proceedings of the National Academy of Sciences, 1996
• The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer
  Cell, 1996
• The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers
  Cell, 1996
• Fhit, a Putative Tumor Suppressor in Humans, Is a Dinucleoside 5‘,5‘ ‘‘-P¹,P³-Triphosphate Hydrolase
  Biochemistry, 1996
• Comparative genomic analysis of tumors: detection of DNA losses and amplification.
  Proceedings of the National Academy of Sciences, 1995
• Announcement
  Gynecologic Oncology, 1986